The following categories are available for abstract submission. Each abstract may be submitted to only one category:
Best Practices for Improving Cancer Immunotherapy Treatment Administration and Polypharmacy Management*
Biomarkers and Immune Monitoring
Cancer Vaccines
Case Studies demonstrating exceptional responses or best practices for management of irAEs*
Cellular Metabolism and Antitumor Immunity
Cellular Therapy Approaches
Clinical Trials (In Progress)
Clinical Trials (Completed)
Combination Therapy (IO/IO, IO/Standard of Care, IO/Other)
Emerging Models and Imaging
Oncogenetics and Immunogenomics
Immune Modulation, Cytokines, and Antibodies
Impact of Diet, Exercise, and/or Stress on Antitumor Immunity
irAE Management: Clinical Care and Best Practices*
Mechanisms of Efficacy or Toxicity
Mechanisms of Resistance to Immunotherapy
Microbiome
Patient Experience: Patient Education Regarding Immunotherapy and Side Effect Management*
Personalized Vaccines and Technologies/Personalized Medicine
Oncolytic Viruses and Intratumoral Therapies
Other
Tumor Microenvironment (Mechanisms and Therapies)
*These categories are Physician/Nurse/Pharmacy categories however anyone with applicable abstracts who does not fit into the aforementioned demographic is welcome to submit